Biotech grants in South Korea

Closed

Funds clinical and pre-clinical research that pins down the causes of, and builds better diagnostics and treatments for, medical conditions that are common but poorly understood, such as ME/CFS, autism, gynaecological diseases and low back pain.

Closed

Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.

Closed

Pays biomedical New Approach Methodology developers a fixed EUR 300,000 lump-sum grant to validate animal-free testing methods and prepare them for regulatory use.

Closed

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.

Closed

Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.

Closed

Funds AI and digital-twin tools that speed up bio-based manufacturing — from biorefinery process control to predicting biosynthesis pathways.

Closed

Funds a full-scale flagship biorefinery that turns separately-collected urban bio-waste into higher-value bio-based products instead of compost or biomethane.

Closed

Funds the advancement of existing vaccine candidates against one named epidemic-prone virus, from lab testing through to a first human safety trial.

Closed

Funds research into new tools and conversion routes that turn low-value forest residues into bio-based chemicals, materials or products beyond bioenergy.

Open

Funds Korean startups and small and medium-sized enterprises through low-interest loans managed by KOSME and the Ministry of enterprise and innovation support.

Between cycles

Funds Korean startups building products and market access with global companies through open-innovation projects.

Between cycles

Funds Korean venture-stage companies with market-development support and loan guarantees to accelerate scaling.

Between cycles

Funds Korean SMEs entering overseas markets through projects run with companies that already have global channels.

Between cycles

Funds Korean startups solving defined technology problems with large companies and public institutions.

Closed

Supports foreign-founded startups entering Korea with market localization and expansion assistance.

Closed

Funds Korean micro-enterprises turning proven export demand into products, brands, certifications, and overseas sales.

Closed

Gives free mentoring and pitch coaching to international student founders building in Korea.

Closed

Funds high-growth Korean technology companies scaling overseas, raising global capital, and preparing for public markets.

Discontinued

Provides collateral-light access to bank financing in Korea through technology-based credit guarantees for innovative startups and small businesses.

Open

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

Open

Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.

Open

Pays an equity-free cash prize to the top healthcare startup pitching live at WHX Tech's Xcelerate competition in Dubai.

Open

Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.

Open

Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.